Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$133.26 +0.2%	$132.30	$99.71 ▼ $141.23	$231.38B	0.73	6.10 million shs	4.88 million shs
NVS Novartis	$117.56 +1.5%	$113.22	$96.06 ▼ $120.92	$244.56B	0.59	1.58 million shs	1.15 million shs
PFE Pfizer	$24.04 +0.3%	$23.30	$20.92 ▼ $31.54	$136.28B	0.57	41.30 million shs	31.91 million shs
TMO Thermo Fisher Scientific	$400.26 +0.6%	$411.66	$385.46 ▼ $627.88	$150.20B	0.78	1.94 million shs	2.49 million shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	+0.28%	-0.54%	+1.49%	+6.22%	+26.05%
NVS Novartis	+1.68%	-0.49%	+4.25%	+6.57%	+11.73%
PFE Pfizer	+0.30%	-1.46%	+3.03%	-5.95%	-13.34%
TMO Thermo Fisher Scientific	+0.74%	-1.21%	+1.71%	-22.09%	-29.11%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABT Abbott Laboratories	4.9348 of 5 stars	2.4	5.0	4.2	4.5	3.0	2.5	2.5
NVS Novartis	1.9253 of 5 stars	1.0	4.0	2.5	0.0	3.0	0.0	1.9
PFE Pfizer	4.8605 of 5 stars	2.3	4.0	4.2	4.3	2.3	1.7	3.1
TMO Thermo Fisher Scientific	4.9877 of 5 stars	4.4	3.0	2.5	4.1	3.6	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.76	Moderate Buy	$142.61	7.02% Upside
NVS Novartis	2.00	Hold	$123.38	4.95% Upside
PFE Pfizer	2.53	Moderate Buy	$29.17	21.33% Upside
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$605.30	51.23% Upside

Current Analyst Ratings Breakdown

Latest TMO, NVS, ABT, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	ABT Abbott Laboratories	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
6/16/2025	ABT Abbott Laboratories	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$143.00
4/30/2025	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$24.00 ➝ $25.00
4/29/2025	TMO Thermo Fisher Scientific	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$620.00 ➝ $470.00
4/25/2025	TMO Thermo Fisher Scientific	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$650.00 ➝ $605.00
4/24/2025	TMO Thermo Fisher Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$651.00 ➝ $637.00
4/24/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$715.00 ➝ $500.00
4/24/2025	TMO Thermo Fisher Scientific	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$665.00 ➝ $620.00
4/24/2025	TMO Thermo Fisher Scientific	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$585.00 ➝ $500.00
4/24/2025	TMO Thermo Fisher Scientific	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$580.00 ➝ $570.00
4/24/2025	TMO Thermo Fisher Scientific	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$603.00 ➝ $573.00

(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$41.95B	5.53	$6.60 per share	20.20	$27.62 per share	4.82
NVS Novartis	$50.32B	4.94	$10.87 per share	10.82	$21.59 per share	5.45
PFE Pfizer	$63.63B	2.15	$4.38 per share	5.49	$15.62 per share	1.54
TMO Thermo Fisher Scientific	$42.88B	3.52	$30.21 per share	13.25	$129.54 per share	3.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$13.40B	$7.71	17.28	23.26	2.53	31.89%	19.01%	10.82%	7/17/2025 (Estimated)
NVS Novartis	$11.94B	$6.40	18.37	13.34	1.67	24.70%	39.44%	16.43%	7/17/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	17.42	7.93	0.87	12.62%	20.33%	8.53%	7/29/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.05	23.48	15.66	2.10	15.19%	17.15%	8.47%	7/23/2025 (Estimated)

Latest TMO, NVS, ABT, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/17/2025	Q2 2025	ABT Abbott Laboratories	$1.25	N/A	N/A	N/A	$11.01 billion	N/A
7/17/2025	Q2 2025	NVS Novartis	$2.37	N/A	N/A	N/A	$13.94 billion	N/A
4/29/2025	Q1 2025	NVS Novartis	$2.12	$2.28	+$0.16	$1.83	$12.92 billion	$13.23 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/23/2025	Q1 2025	TMO Thermo Fisher Scientific	$5.10	$5.15	+$0.05	$3.98	$10.23 billion	$10.36 billion
4/16/2025	Q1 2025	ABT Abbott Laboratories	$1.07	$1.09	+$0.02	$0.76	$10.38 billion	$10.36 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.36	1.77%	N/A	30.61%	54 Years
NVS Novartis	$2.60	2.21%	N/A	40.63%	N/A
PFE Pfizer	$1.72	7.15%	N/A	124.64%	16 Years
TMO Thermo Fisher Scientific	$1.72	0.43%	N/A	10.09%	8 Years

Latest TMO, NVS, ABT, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/13/2025	ABT Abbott Laboratories	quarterly	$0.59	1.73%	7/15/2025	7/15/2025	8/15/2025
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.26	1.78	1.27
NVS Novartis	0.56	0.79	0.61
PFE Pfizer	0.64	1.26	0.96
TMO Thermo Fisher Scientific	0.64	1.77	1.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
NVS Novartis	13.12%
PFE Pfizer	68.36%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
NVS Novartis	0.01%
PFE Pfizer	0.06%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	114,000	1.74 billion	1.73 billion	Optionable
NVS Novartis	75,883	2.11 billion	2.11 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
TMO Thermo Fisher Scientific	125,000	377.49 million	376.25 million	Optionable

TMO, NVS, ABT, and PFE Headlines

Recent News About These Companies

Thermo Fisher lands $94.5M Navy contract, will add staff in Oakwood Village

June 24 at 12:47 AM | crainscleveland.com

Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems

June 23 at 8:30 AM | businesswire.com

Oppenheimer & Co. Inc. Purchases 814 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 23 at 7:20 AM | marketbeat.com

Oppenheimer Asset Management Inc. Purchases 4,605 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 23 at 7:19 AM | marketbeat.com

Palumbo Wealth Management LLC Grows Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 23 at 5:59 AM | marketbeat.com

Verde Servicos Internacionais S.A. Boosts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 23 at 5:42 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Acquired by Live Oak Private Wealth LLC

June 23 at 5:23 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) is Coho Partners Ltd.'s 7th Largest Position

June 22 at 6:37 AM | marketbeat.com

Kentucky Retirement Systems Insurance Trust Fund Sells 1,688 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 22 at 6:21 AM | marketbeat.com

Manning & Napier Advisors LLC Has $180.68 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 22 at 6:20 AM | marketbeat.com

Guyasuta Investment Advisors Inc. Reduces Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 22 at 6:08 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Matrix Asset Advisors Inc. NY

June 22 at 5:13 AM | marketbeat.com

First American Bank Has $14.73 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 7:30 AM | marketbeat.com

Nilsine Partners LLC Increases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 7:09 AM | marketbeat.com

Canton Hathaway LLC Has $1.13 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 7:08 AM | marketbeat.com

Praxis Investment Management Inc. Has $8.32 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 6:42 AM | marketbeat.com

Marietta Wealth Management LLC Has $7.66 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 6:34 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Acquired by GAM Holding AG

June 21 at 6:24 AM | marketbeat.com

Worth Financial Advisory Group LLC Purchases 1,185 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 5:59 AM | marketbeat.com

Canoe Financial LP Buys New Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 5:41 AM | marketbeat.com

Dupont Capital Management Corp Sells 2,208 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 21 at 5:31 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO, NVS, ABT, and PFE Company Descriptions

Abbott Laboratories NYSE:ABT

$133.26 +0.27 (+0.20%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$133.79 +0.53 (+0.40%)

As of 06/23/2025 07:58 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Novartis NYSE:NVS

$117.56 +1.79 (+1.55%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$116.65 -0.91 (-0.77%)

As of 06/23/2025 07:41 PM Eastern

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Pfizer NYSE:PFE

$24.04 +0.07 (+0.29%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$24.04 0.00 (-0.02%)

As of 06/23/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Thermo Fisher Scientific NYSE:TMO

$400.26 +2.38 (+0.60%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$401.60 +1.35 (+0.34%)

As of 06/23/2025 07:57 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time